Platelet-Rich Plasma vs Extracorporeal Shock Wave Therapy in the Treatment of Plantar Fasciitis at 3-6 Months: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Daher M, Covarrubias O, Herber A, Oh I, Gianakos A. Platelet-Rich Plasma vs Extracorporeal Shock Wave Therapy in the Treatment of Plantar Fasciitis at 3-6 Months: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Foot & Ankle International 2024, 45: 796-803. PMID: 38419209, DOI: 10.1177/10711007241231959.Peer-Reviewed Original ResearchPlantar fascia thicknessExtracorporeal shock wave therapyRandomized controlled trialsPlatelet-rich plasmaPlantar fasciitisPlatelet-rich plasma groupShock wave therapyVisual analog scaleFascia thicknessControlled trialsMeta-analysisTreatment of plantar fasciitisExtracorporeal shock wave therapy groupPain scoresWave therapyVisual analog scale painMeta-analysis of randomized controlled trialsEffect of platelet-rich plasmaVAS pain scoresHigher pain reductionManagement of PFFoot disordersSystematic reviewInclusion criteriaPain reduction